Acumen Pharmaceuticals has dosed the first patient in the ALTITUDE-AD Phase II trial for its lead drug sabirnetug (ACU193).
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AßOs) for the treatment of Alzheimer’s ...
In the ALTITUDE-AD trial, researchers will measure patients' disease progression on various Alzheimer's scales and track changes in amyloid and tau biomarkers.
CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble ...
Acumen is hosting a complimentary half-day Revenue Management Forum for FMCG senior leaders in Sydney. The Forum will feature ...
CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble ...
Speaking at the inaugural ceremony of Science Spectra, Dilip Shah, Rector and Dean of Student Affairs, at The Bhawanipur ...
A Brentwood high school student took top-10 honors in an annual conference for aspiring student business leaders last month.
Real Madrid claimed a record-extending 36th LaLiga title on Saturday after Girona's 4-2 thrashing of local rivals Barcelona ...
France 24 on MSN7d
Ancelotti's tactical acumen leads Real to 36th LaLiga titleReal Madrid claimed a record-extending 36th LaLiga title on Saturday after Girona's 4-2 thrashing of local rivals Barcelona ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback